Clinical Trials Logo

Filter by:
NCT ID: NCT03547089 Suspended - Sexual Dysfunction Clinical Trials

A Prospective Trial to Assess Breast Cancer Survivors and Vaginal Atrophy Treatment Outcomes

BRAVO
Start date: August 1, 2018
Phase: N/A
Study type: Interventional

The focus of this study is to assess breast cancer survivors perspectives of Viveve® Treatment using patient reported outcome tools with a focus on symptoms associated with vulvovaginal atrophy/genitourinary syndrome of menopause (GSM). This will be assessed by the FSFI, FSDS-R and DIVA questionnaires.

NCT ID: NCT03546335 Suspended - Clinical trials for Rheumatoid Arthritis

Zr-89 Cimzia PET Imaging Rheumatoid Arthritis

Start date: October 1, 2018
Phase: Phase 1
Study type: Interventional

This is a single center exploratory imaging study investigating the initial application of zirconium-89 Deferoxamine B Certolizumab pegol (89Zr-DFO-CZP) PET in patients with rheumatoid arthritis. Patients with active symptoms of RA or signs on physical exam will be invited to participate for PET imaging.

NCT ID: NCT03535584 Suspended - Frailty Clinical Trials

Exercise to Treat Frailty and Decreased Physical Function in Transplant Candidates

Start date: June 12, 2018
Phase: N/A
Study type: Interventional

Frailty is a condition characterized by slowness, weakness, low physical activity, wasting, and exhaustion. Frailty increases the risk for adverse outcomes following transplant such as increased length of stay in the hospital, mortality, or graft function. No interventions for frailty are known for patients with renal disease, but exercise programs like pulmonary rehabilitation have been effective in improving frailty in patients with other diseases, such as lung disease. The goal of this study is to test whether exercise will also improve frailty among patients who are waiting for a kidney transplant and who are considered frail or pre-frail.

NCT ID: NCT03534193 Suspended - Clinical trials for Type 1 Diabetes Mellitus

Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes

Start date: April 17, 2017
Phase: N/A
Study type: Interventional

This is a prospective, randomized trial to evaluate the effectiveness of using educational modules accessed through a bedside tablet in patients newly diagnosed with Type 1 Diabetes as an adjunct to *standard Children's Hospital- Molly Center diabetes education in comparison to *standard Children's Hospital- Molly Center diabetes education. (standard diabetes education consists of paper based reading material and nursing education).

NCT ID: NCT03520751 Suspended - Clinical trials for Charcot-Marie-Tooth Neuropathy Type 1A

Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A

Start date: April 2025
Phase: Phase 1/Phase 2
Study type: Interventional

This clinical trial is an open-label one-time injection dose study in which scAAV1.tMCK.NTF3 will be administered by intramuscular injections into muscles in both legs in CMT1A subjects with PMP22 gene duplication. Three subjects ages 18 to 35 years receiving (8.87e11 vg/kg) will be enrolled.

NCT ID: NCT03508739 Suspended - Hypertension Clinical Trials

Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition

Start date: June 1, 2018
Phase: Phase 3
Study type: Interventional

Type 2 diabetes is common, increases in prevalence with age, and patients with diabetes have an increased risk of cardiovascular disease. A relatively new cardiovascular medication currently used for the treatment of heart failure in the United States inhibits an enzyme that breaks down a variety of signaling hormones. This clinical trial tests if it may also be a target for the treatment of diabetes by decreasing the breakdown of a hormone that increases insulin release after a meal.

NCT ID: NCT03508479 Suspended - Healthy Volunteers Clinical Trials

Study of Airway Inflammatory Responses to Experimental Rhinovirus Infection

Start date: March 2024
Phase: Phase 1
Study type: Interventional

This study is designed to characterize in detail the clinical, physiologic, and inflammatory features of Human Rhinovirus (HRV) infection in healthy volunteers without underlying lung disease while also evaluating the safety of HRV administrations.

NCT ID: NCT03502499 Suspended - Clinical trials for Ventricular Arrythmia

Half-normal Saline in Idiopathic Left Ventricular Outflow Tract Arrhythmias Ablation

Start date: May 16, 2018
Phase: N/A
Study type: Interventional

The study evaluates the use of half-normal saline as an irrigant for open-irrigated catheters during left ventricular outflow tract ventricular arrhythmias ablation. By increasing the efficacy of radiofrequency energy-mediated lesion formation, half-normal saline has the potential to reduce procedural times and improved acute and long-term outcomes.

NCT ID: NCT03500770 Suspended - Lyme Disease Clinical Trials

Lyme Disease Patients With Memory Problems

Start date: February 20, 2019
Phase: N/A
Study type: Interventional

The main purpose of this study is to see if a device known as Transcranial Direct Current Stimulator (tDCS) is helpful in reducing persistent symptoms after Lyme disease treatment. Some of these symptoms include problems with memory, fatigue or pain.

NCT ID: NCT03498391 Suspended - Clinical trials for Anesthesia Awareness

A Study of Human Multi-Sensory Integration

MSI
Start date: July 30, 2018
Phase: Phase 2
Study type: Interventional

The primary aim of this study is to determine whether spatiotemporal characteristics of multisensory evoked potentials can be used as a marker of consciousness (awareness) under anesthesia. The secondary aim is to characterize changes in the characteristics of evoked potentials under anesthesia in both single sensory modality (visual, auditory) and across sensory modalities.